Metformin utilisation in Australian community and aged care settings

Diabetes Research and Clinical Practice
Weiyi HuangRonald L Castelino

Abstract

The objective of this study was to: (i) evaluate the potentially inappropriate prescribing (PIP; defined as the use of metformin in the presence of contraindications and/or use in excessive dosage based on the renal function) of metformin in people receiving medication reviews in Australia and (ii) identify the predictors for PIP of metformin. Retrospective study of patients taking metformin through a large medication review database, containing records between January 2010 and June 2012. Data, including demographics, medical conditions, medications and relevant pathology results, were extracted for analysis. Multivariate logistic regression analysis was used to detect risk factors for PIP of metformin. Medication reviews pertaining to 6386 patients who received Home Medicines Reviews (HMRs, n=5327) or Residential Medication Management Reviews (RMMRs, n=1059) were included in this study. Overall, there were 12.9% (n=685) of patients in the HMR group and 17.4% (n=184) of patients in the RMMR group who had PIP of metformin. Multivariate logistic regression showed age, gender and type of medication review service as the significant (p<0.05) independent risk factors for PIP of metformin. Metformin was often used in patients with co...Continue Reading

References

Sep 7, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·A HolsteinE H Egberts
Nov 18, 2000·Journal of the American Geriatrics Society·A PapaioannouM Bédard
Jul 27, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·A M Emslie-SmithUNKNOWN DARTS/MEMO Collaboration
Jan 30, 2004·Journal of Internal Medicine·A M E StadesJ B L Hoekstra
Feb 3, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Edoardo G GianniniVincenzo Savarino
Nov 12, 2005·Diabetologia·A Holstein, M Stumvoll
Jul 4, 2006·Advances in Chronic Kidney Disease·Robert N Foley
Sep 1, 2007·BMJ : British Medical Journal·Dean T EurichJeffrey A Johnson
Sep 8, 2007·BMJ : British Medical Journal·A A TahraniF W F Hanna
Aug 13, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jean-Daniel Lalau
Jun 2, 2012·Diabetes Research and Clinical Practice·Ilhan SatmanUNKNOWN ADMIRE Study Group
Dec 25, 2013·Reproductive Biomedicine Online·Isabelle StreuliDominique de Ziegler
Jan 11, 2014·Internal Medicine Journal·W HuangG M Peterson
Feb 11, 2014·Diabetes Research and Clinical Practice
Jun 23, 2015·Journal of Pain & Palliative Care Pharmacotherapy· U S Department Of Health And Human Services

❮ Previous
Next ❯

Citations

Aug 29, 2016·European Journal of Clinical Pharmacology·J MoonR O Day

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.